Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type
- 29 January 2009
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 64 (2) , 101-107
- https://doi.org/10.1111/j.1600-0404.1981.tb04392.x
Abstract
The possibility of disturbed dopamine and serotonin metabolism in senile dementia of Alzheimer type was studied. Basal concentrations of homovanillic acid (HVA) and 5-hydroxyIAA (5-HIAA) in CSF were studied in 28 patients with senile dementia of Alzheimer type and in 13 controls age with no neurological disease. Concentrations of HVA were significantly reduced in the dementia patients compared to concentrations of controls. Values of HVA were also significantly reduced in the most severely demented patients compared to the less severely demented ones. There was a slight but statistically significant decrease in the 5-HIAA levels in the dementia patients compared to the levels of the controls. 5-HIAA levels were reduced in the most severely demented patients compared to the controls but not when compared with the less severely demented patients. In severe forms of senile dementia of Alzheimer type, there is apparently a decrease in the levels of HVA and 5-HIAA in CSF which may reflect a decreased turnover of dopamine and serotonin. Patients diagnosed as senile dementia of Alzheimer type, but with less severe symptoms, had levels of HVA and 5-HIAA similar to controls.Keywords
This publication has 15 references indexed in Scilit:
- Biochemistry of dementia and normal ageingTrends in Neurosciences, 1980
- Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer TypeThe British Journal of Psychiatry, 1979
- Dendro axonic neurotransmission. II. Morphological sites for the synthesis, binding and release of neurotransmitters in dopaminergic dendrites in the substantia nigra and cholinergic dendrites in the neostriatumBrain Research, 1979
- ACCELERATED AGEING OR SELECTIVE NEURONAL LOSS AS AN IMPORTANT CAUSE OF DEMENTIA?The Lancet, 1979
- Isolation and assay of noradrenaline, dopamine, 5-hydroxy-tryptamine, and several metabolites from brain tissue using disposable bio-rad columns packed with sephadex G-10Journal of Pharmacological Methods, 1978
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- EXTRAPYRAMIDAL DEMENTIA AND LEVODOPAThe Lancet, 1975
- Cerebrospinal Fluid pH and Monoamine and Glucolytic Metabolites in Alzheimer's DiseaseThe British Journal of Psychiatry, 1974
- The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile DementiaThe British Journal of Psychiatry, 1969
- The effect of neuroleptics on the activity of central catecholamine neuronesLife Sciences, 1967